# Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)

> **NCT02460432** · NA · COMPLETED · sponsor: **Taewoong Medical Co., Ltd.** · enrollment: 106 (actual)

## Conditions studied

- Biliary Neoplasms
- Biliary Obstruction
- Pancreatic Neoplasms

## Interventions

- **DEVICE:** Paclitaxel-eluting metal Stent
- **DEVICE:** Covered Metal Stent

## Key facts

- **NCT ID:** NCT02460432
- **Lead sponsor:** Taewoong Medical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-12-26
- **Final completion:** 2016-12-26
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2017-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02460432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02460432, "Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02460432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*